​

Third Harmonic Bio (THRD) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

THRD Stock Forecast

Third Harmonic Bio (THRD) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $16.15, with a high of $23.00 and a low of $3.60. This represents a 198.52% increase from the last price of $5.41.

- $5 $10 $15 $20 $25 High: $23 Avg: $16.15 Low: $3.6 Last Closed Price: $5.41

THRD Stock Rating

Third Harmonic Bio stock's rating consensus is Hold, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (25.00%), 3 Hold (75.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 4 0 3 1 Strong Sell Sell Hold Buy Strong Buy

THRD Price Target Upside V Benchmarks

TypeNameUpside
StockThird Harmonic Bio198.52%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$21.50
Last Closing Price$5.41$5.41$5.41
Upside/Downside--297.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-11--2
May, 25-13--4
Apr, 25-14--5
Mar, 25-13--4
Feb, 25231--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 09, 2024Michael UlzMorgan Stanley$20.00$10.8684.16%269.69%
Jun 17, 2024Alex ThompsonStifel Nicolaus$23.00$12.9577.61%325.14%
Jun 07, 2024Laura PrendergastRaymond James$18.00$14.4924.22%232.72%
Dec 16, 2022Morgan Stanley$5.00$4.2717.10%-7.58%
Dec 16, 2022Jefferies$3.60$4.30-16.28%-33.46%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 08, 2024Morgan StanleyEqual-WeightOverweightupgrade
Jun 06, 2024Raymond JamesOutperforminitialise
Dec 16, 2022Morgan StanleyEqual-Weightdowngrade

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.78$1.09----
Avg Forecast$-1.11$-1.15$-1.45$-1.88$-2.16$-2.40
High Forecast$-1.11$-1.00$-1.30$-1.57$-1.53$-2.40
Low Forecast$-1.11$-1.28$-1.61$-2.30$-2.98$-2.40
Surprise %-29.73%-194.78%----

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-30.82M$45.47M----
Avg Forecast$-44.08M$-45.13M$-57.59M$-76.60M$-108.71M$-94.95M
High Forecast$-44.08M$-39.57M$-51.50M$-62.05M$-60.82M$-94.95M
Low Forecast$-44.08M$-50.70M$-63.68M$-91.14M$-118.01M$-94.95M
Surprise %-30.07%-200.75%----

THRD Forecast FAQ

Is Third Harmonic Bio stock a buy?

Third Harmonic Bio stock has a consensus rating of Hold, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Third Harmonic Bio is a neutral investment for most analysts.

What is Third Harmonic Bio's price target?

Third Harmonic Bio's price target, set by 4 Wall Street analysts, averages $16.15 over the next 12 months. The price target range spans from $3.6 at the low end to $23 at the high end, suggesting a potential 198.52% change from the previous closing price of $5.41.

How does Third Harmonic Bio stock forecast compare to its benchmarks?

Third Harmonic Bio's stock forecast shows a 198.52% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Third Harmonic Bio over the past three months?

  • June 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.

What is Third Harmonic Bio’s EPS forecast?

Third Harmonic Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.45, marking a -233.03% decrease from the reported $1.09 in 2024. Estimates for the following years are $-1.88 in 2026, $-2.16 in 2027, and $-2.4 in 2028.

What is Third Harmonic Bio’s revenue forecast?

Third Harmonic Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $0 for 2027, and $0 for 2028.

What is Third Harmonic Bio’s net income forecast?

Third Harmonic Bio's net income forecast for the fiscal year ending in December 2025 stands at $-57.59M, representing a -226.66% decrease from the reported $45.47M in 2024. Projections indicate $-76.597M in 2026, $-109M in 2027, and $-94.95M in 2028.